Prescription RequiredBaricitinib is an oral JAK inhibitor that reduces excessive immune activity and inflammation. Depending on local approval, it may be prescribed for rheumatoid arthritis, severe alopecia areata, atopic dermatitis or selected hospitalised patients with severe COVID-19.
| Generic Name | Baricitinib |
| Strength | 4 mg |
| Manufacturer | Eli Lilly and Company |
| Packing | 7 Tablets |
| Prescribed For | Treat moderate to severe rheumatoid arthritis, severe alopecia areata, and certain hospitalized patients with COVID-19 requiring supplemental oxygen |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
Baricitinib blocks the Janus kinase enzymes JAK1 and JAK2. These enzymes transmit signals from inflammatory substances to immune cells. Blocking the pathway reduces excessive inflammation and immune activity responsible for joint, skin and hair-related symptoms.
Baricitinib prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.
Dr. Anjali Desai holds a Doctor of Medicine (MD) degree and has a professional interest in rheumatoid arthritis and joint care. Her interests include managing symptoms, monitoring disease progression, supporting treatment plans and improving patients’ quality of life.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
